Induced Pluripotent Stem Cell (iPS Cell) Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 25
SKU : PH3457
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
Which region holds the largest market share of global induced pluripotent stem cell (iPS Cell) market ?
North America region holds the largest market share of global induced pluripotent stem cell (iPS Cell) market
Who are the key players in Induced Pluripotent Stem Cell (iPS Cell) Market ?
Major players are Axol Bioscience Ltd, Cynata Therapeutics Limited, Evotec SE, FUJIFILM Cellular Dynamics, Inc, Ncardia, Pluricell Biotech, REPROCELL USA, Inc, Sumitomo Dainippon Pharma Co., Ltd, Takara Bio, Inc, Thermo Fisher Scientific, Inc, Shenzhen Haodi Huatuo Biotechnology Co., Ltd, Wuxi Yingnuui Biomedical Technology, Shanghai Haoran Biotechnology Co., Ltd, ScienCell Research Laboratories, Inc and Beijing Lebo Biotechnology Co., Ltd.
Related Reports
pharmaceuticals

Cancer Stem Cell Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 April 29
Starting from

$5350

pharmaceuticals

Limbal Stem Cells Deficiency Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 09
Starting from

$4350

biotechnology

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350